Filing
4th Quarter - Report
Bills named in this filing
1
Lobbying activity
1
General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act